在胆道癌症中,BCLAF1被表达为潜在的抗瘤基因
Yutong Zhou1, Xun Ran2, Min Han3,4
1Department of Postgraduates, Guizhou Medical University, Guizhou, China.
Biochemical genetics
|January 10, 2024
概括
在胆道癌症中,BCLAF1充当抗瘤基因,抑制HIF-1α并影响免疫细胞透. 它的高表达与晚期相对应,但死亡率较低,这表明它在瘤进展中起着复杂的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胆管癌 (BDC) 是一种具有挑战性的恶性瘤,治疗选择有限.
- 在BDC发展和进展的基础上,精确的分子机制仍然不完全理解.
- 确定新的治疗点和了解瘤抑制剂的作用对于改善患者的治疗结果至关重要.
研究的目的:
- 研究BCLAF1在胆道癌的发展和进展中的作用.
- 探索BCLAF1表达与关键细胞过程之间的相关性,包括免疫透和缺氧反应.
- 确定BCLAF1作为BDC中的抗瘤基因的潜力.
主要方法:
- 对BCLAF1在BDC与正常组织中的差异性表达的生物信息分析.
- 使用TIMER算法进行免疫透分析.
- 在不同氧气条件下,通过西部血栓检测,qRT-PCR和划伤试验验验证的BCLAF1和HIF-1α表达之间的相关性分析.
- 进行KEGG和GO丰富分析以确定相关的分子通路.
主要成果:
- 在BDC瘤组织中,BCLAF1mRNA水平显著升高.
- 高BCLAF1表达与晚期BDC阶段相关,但矛盾的是死亡率较低.
- 过度表达BCLAF1与胰岛素修饰,基素修饰和宏分子甲基化有关.
- BCLAF1表达与免疫细胞透正相关,与HIF-1α表达负相关,特别是在低氧状态下.
- 实验验证证证实了BCLAF1和HIF-1α之间的正相关性,其中BCLAF1可能会抑制HIF-1α.
结论:
- 在胆道癌症中,BCLAF1作为抗瘤基因起作用.
- BCLAF1在调节BDC微环境中的免疫细胞透中发挥作用.
- BCLAF1与HIF-1α的相互作用表明其在BDC中的瘤抑制活性的机制.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K


